Aldosterone to renin ratio (ARR) is a marker of inappropriate aldosterone activity in hypertension. Since aldosterone may adversely affect vascular compliance, we hypothesised that the ARR would relate to exercise blood pressure (BP) responses in hypertension. Blood sampling was done in untreated hypertensives for plasma renin activity (PRA, ng/mL/hr) and plasma aldosterone (PA, pmol/L). ARR was derived by dividing the PA value by the PRA value, and this index was normalised by natural logarithm (lnARR) for further analyses. Each patient underwent 24-h ambulatory BP (ABP), and a 3-min submaximal exercise test using the Dundee
Introduction
The renin-angiotensin-aldosterone system may be involved in maintaining hypertension. However, significant and consistent relationships between the absolute levels of these component hormones (renin, angiotensin II and aldosterone) with blood pressure (BP) have not been found. 1 This is partly because the levels of these hormones are highly labile within the individual. The secretions of these hormones are influenced by body posture, salt intake, physical activity and time of the day blood sampling is done. More recently, the aldosterone to renin ratio (ARR) has emerged as an index of 'inappropriate aldosterone activity' for which blood sampling could be easily done in the out-patient department, but has inherently better reproducibility in dissecting out the various aetiological contributions to hypertension. 2 This index relates to plasma sodium (directly) and potassium (inversely) in essential hypertension, 3 the two consistent and basic electrolyte features of this disease. 4 This inappropriate aldosterone activity in hypertension may also have a genetic basis, relating to aldosterone synthase (CYP11B2) genetic polymorphism. [5] [6] [7] ARR might be associated with abnormal vascular compliance and impaired peripheral vasodilatory capacity in hypertension. These factors would predispose to high BP during exercise through elevated systemic vascular resistance which fails to fall appropriately during exercise. 8 Thus we hypothesised that ARR would relate to BP responses during exercise more than BPs measured at rest or with ambulatory methods. If this assertion is correct, then this would further emphasise the importance of inappropriate aldosterone activity as being aetiologically important in the pathogenesis and mainte-Journal of Human Hypertension nance of hypertension, and that exercise testing could unmask this underlying abnormality 'quantitatively' better than office BP. This would give credence to the findings that exercise BP is a more potent predictor of cardiovascular mortality than office BP.
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Subjects and methods
Participants
We studied patients referred to our specialist hypertension clinic for assessment. These subjects all had raised office BP readings (systolic BP у160 and/or diastolic BP у90 mm Hg) confirmed over a period of at least 3 months prior to their referral by primarycare physicians. We excluded subjects who were unable to exercise. Prior to being studied, subjects who were taking antihypertensive therapy had their treatment withdrawn for 7 to 10 days if there were no contraindications, such as previous history of accelerated hypertension, ischaemic heart disease or cerebrovascular disease. Blood samples (10 ml) were taken between 14.00 to 17.00 for electrolytes as well as for plasma renin activity (PRA ng/ml/hr) and aldosterone (pmol/l) after the patients had been sitting quietly for about 10 min. ARR was derived by dividing plasma aldosterone with PRA, and this ratio was normalised with natural logarithm before statistical analyses were done.
Blood pressure measurements
BP was measured in triplicate by trained hypertension research nurses using a standard mercury sphygmomanometer at 1-min intervals after patients had been sitting quietly for 2 min. The mean of these three readings was used to define office BP. Each patient then underwent a single-stage lightweight (equivalent to 50W on a bicycle ergometer) submaximal Dundee Step Test, the methodology of which has been described elsewhere. 10 Briefly, the exercise BP was measured during exercise following 3 min of stepping at a rate of 92 per min on a step with a height of 17.5 cm. A 24-h ambulatory BP (ABP) (Spacelabs 90207, Redmond, WA, USA) was then obtained from each patient on an active day.
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The device was programmed to measure BP every 15 min during daytime and at half hourly intervals during night-time, daytime being defined as the period between 08.00 to 22.00. The following spurious readings were discarded by editing software; systolic BP Ͻ diastolic BP, diastolic BP Ͼ160 or Ͻ40 mm Hg and systolic BP Ͼ260 mm Hg or Ͻ50 mm Hg. The 24-h, daytime and night-time mean ABPs were analysed.
Laboratory testing
Plasma renin activity (PRA) was measured using Biodata Renin MAIA assay (Serono Diagnostics Ltd, Working, Surrey) with an intraassay coefficient of variation of Ͻ10% between 0.3 and 18 ng/ml/h, and a least detectable concentration of 0.3 mg/ml/hr. Plasma aldosterone was measured using a solidphase (coated tube) radioimmunoassay technique, DPC Coat-a-Count assay (DPC, Llanberis, Caernarfon, Gwynedd) with an intraassay coefficient of variation of Ͻ10% between 200 and 3300 pmol/l, and a least detectable concentration of 70 pmol/l.
Statistical methods
Data on continuous variables were tabulated as means and standard deviations. Categorical variables were tabulated as percentages along with their numerators. Initially the correlation of the various measures of BP were tabulated with the outcome variable of InARR. Correlations were estimated using the Spearman rank method as not all the variables were normally distributed.
The relationships between BP measurements and the ARR were assessed in multiple linear regression. Initially age and sex were forced into the model and then a stepwise procedure for the BP variables was carried out. In addition, full models were also fitted with age, sex and all BP measurements forced into the model. Subsequently, natural log transformations were carried out for the outcome of ARR. Linear relationships were assumed for predictors. All statistical analyses were carried out using SAS (version 6.12). Table 1 shows the characteristics of the sample (n ϭ 119). The mean age of the sample was 48 years (s.d. 12 years), and 56% of the sample were male. The BP measurements are tabulated in Table 2 . The 24-h mean systolic ABP was 140 mm Hg. The highest BP was during exercise with a mean of 189 mm Hg.
Results
Characteristics of the study population
Correlation and regression analyses
Initially correlations were estimated using the Spearman Rank method (Table 3) . Individually, neither plasma aldosterone nor PRA correlated with the BP indices. With the log transformed ARR however, the highest correlations were with exercise systolic BP (r s ϭ 0.24) and exercise diastolic BP (r s ϭ 0.23) and 24-h systolic ABP (r s ϭ 0.22) being the highest.
Variables were entered in a stepwise procedure after age and sex had entered the model in the multiple linear regression. In the multiple regression on log transformed ARR, age was highly significant with higher ARR with increasing age (Table 4) . Males had higher ARR but were not statistically different to females. Once age and sex were entered no other variable reached the significance level of 10% for entry. However, when all the BP measurements were entered simultaneously exercise systolic BP was significantly associated with higher InARR (P ϭ 0.012) (Figure 1 ). After adjustment for exercise systolic BP, the change in exercise systolic BP was significantly associated with lower InARR.
Discussion
was significantly associated with higher InARR (P ϭ BP was robust, and was independent of age or gender. Importantly, it provided information which could not be gauged from office or ambulatory BPs. In other words, inappropriate aldosterone activity as suggested by a raised ARR was associated with higher exercise systolic BP. Hypertensive subjects are known to have reduced vascular compliance which causes an impaired reduction in systemic vascular resistance during exercise resulting in a greater rise in exercise systolic BP in comparison to normotensive individuals. 9 The results of our study would suggest that this abnormality could potentially be related to inappropriate aldosterone activity. This link if present may not be surprising, as the role of aldosterone in causing abnormal vascular compliance is generally accepted. 12 The precise mechanism is still unclear but aldosterone has been postulated to increase the tonic contraction of vascular smooth muscles by increasing cellular concentrations of sodium and calcium ions 13 and by causing endothelial dysfunction.
14 In addition, aldo-sterone also contributes to increased vascular collagen deposition and fibrosis. 15 What is new is the concept provided by ARR. As alluded to above, plasma aldosterone per se does not relate to BP levels. The idea of 'inappropriate aldosterone activity' suggests that the levels of plasma aldosterone previously thought to be within the 'laboratory normal ranges' may be abnormal or inappropriately high for a given level of PRA. This index capitalises on the divergence between plasma aldosterone and PRA which has been noted in the past. 16 Under normal physiological circumstances, these two hormones are intimately and directly related to each other. In hypertension, this divergence (high plasma aldosterone and low PRA) is of great interest. Nonetheless, there are other renin-independent pathways for aldosterone secretion, such as changes in plasma potassium, corticotropin and dopamine release. So far, none of these aldosterone secretagogues have been shown to be aetiologically important.
ARR in this study correlated with office, ambulatory and exercise BPs in univariate regression analyses suggesting a consistent relationship which is not observed with plasma aldosterone or renin levels individually. Importantly, the relationship between ARR and exercise systolic BP was independently significant in a multiple regressional analysis after taking age and gender into account. This suggest that exercise BP may be a valid marker of the underlying haemodynamic abnormality related to inappropriate aldosterone activity. The emergence of the change in systolic BP during exercise as a significant predictor of ARR in the multiple regression model but not with univariate analysis was surprising. Intuitively, one would expect a greater rise in BP during exercise if the vascular compliance was reduced. However, hypertensives with more left ventricular hypertrophy have been reported to have a higher baseline BP but a lesser rise in BP during exercise. 17 Since hyperaldosteronism is associated with increased left ventricular mass, 18 it is possible that some of our patients with higher ARR had greater left ventricular mass although we did not have echocardiographic data to support this. It is plausible that left ventricular hypertrophy with its attendant left ventricular diastolic dysfunction may limit the rise in cardiac stroke volume hence reducing the rise of BP during exercise 9 (see below). This would explain our statistical results that patients with higher ARR tended to have a higher baseline BP but a lesser rise in BP during exercise.
It should be borne in mind that the rise in BP during exercise is multifactorial. The intensity of exercise to a large degree determines the level of BP rise, and this may be related to discharges from the sympathetic nervous system. That is, the harder an individual exercises, the higher would the exercise BP rise. We overcame this problem by standardising the workload of our step test, being equivalent to 5 metabolic equivalents (METs), a level which is readily encountered in daily living. 10 Exercise BP is also a composite index, it relates to left ventricular systolic and diastolic function. The presence of impaired systolic function would blunt BP rise, 9 whereas diastolic dysfunction may be associated with an exaggerated BP rise during exercise, 19 but with more advanced degree of diastolic dysfunction, the cardiac stroke volume during exercise fails to increase adequately and this limits BP rise. 9 As aldosterone impairs vascular endothelial function, 14 it would not be surprising that it would also cause left ventricular diastolic dysfunction where there is an excess aldosterone activity, 20 which may interact adversely with dietary salt 21 in producing this functional cardiac abnormality. The key to understanding the pathogenesis of hypertension may be to unravel the mechanism(s) behind this inappropriate aldosterone secretion as represented by a raised ARR.
Conclusions
The correlation between ARR and exercise systolic BP was significant, over and above that of office and ambulatory BPs. This finding is consistent with the hypothesis that 'inappropriate aldosterone activity' in hypertension may contribute to reduced peripheral vascular compliance which could be unmasked by exercise testing.
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